Endothelial Responses to Bacterial Toxins in Sepsis

Critical Reviews in Immunology

Volumn 23, Issue 4, 2003, Pages 267-299

  Grandel, Ulrich ^a   Grimminger, Friedrich ^a,b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Department of Internal Medicine ^*  (Germany)

Author keywords

Bacterial virulence; Endothelial dysfunction; Endotoxin; Exotoxin; Septic shock

Indexed keywords

ANGIOTENSIN; BACTERIAL TOXIN; BACTERIUM LIPOPOLYSACCHARIDE; CATECHOLAMINE; CD14 ANTIGEN; CELL ADHESION MOLECULE; CYTOTOXIN; ENDOTHELIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTOXIN; EXOTOXIN; HEMOLYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOTEICHOIC ACID; LISTERIOLYSIN; NITRIC OXIDE; PEPTIDOGLYCAN; PHOSPHOLIPASE C; PROSTACYCLIN; STAPHYLOCOCCUS ALPHA TOXIN; STREPTOLYSIN O; TOLL LIKE RECEPTOR 4; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL CELL WALL; BACTERIAL VIRULENCE; BLOOD VESSEL REACTIVITY; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM INJURY; ESCHERICHIA COLI; GENE OVEREXPRESSION; HEART FAILURE; HEMOSTASIS; HYPERCOAGULABILITY; INFLAMMATION; INTESTINE; KIDNEY INJURY; LEUKOCYTE ADHERENCE; LISTERIA MONOCYTOGENES; LUNG INSUFFICIENCY; MEDIATOR RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; TOXIN SYNTHESIS; VASCULAR ENDOTHELIUM;

ANIMALS; BACTERIAL TOXINS; ENDOTHELIUM, VASCULAR; ENDOTOXINS; EXOTOXINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; MULTIPLE ORGAN FAILURE; PEPTIDOGLYCAN; SEPSIS; TEICHOIC ACIDS;

EID: 0346749409     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v23.i4.20     Document Type: Review

References (261)

1. Bhakdi S, Grimminger F, Suttorp N, Walmrath D, Seeger W. Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med Microbiol Immunol 1994; 183:119-144.
2. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
3. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
4. Bassenge E. Endothelial function in different organs. Prog Cardiovasc Dis 1996; 39:209-228.
5. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002; 30:S302-S312.
6. Volk T, Kox WJ. Endothelium function in sepsis. Inflamm Res 2000; 49:185-198.
7. Hack CE, Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 2001; 29:S21-S27.
8. Bierhaus A, Chen J, Liliensiek B, Nawroth PP. LPS and cytokine-activated endothelium. Semin Thromb Hemost 2000; 26:571-587.
9. Campbell WN, Fitzpatrick M, Ding X, Jett M, Gemski P, Goldblum SE. SEB is cytotoxic and alters EC barrier function through protein tyrosine phosphorylation in vitro. Am J Physiol 1997; 273:L31-L39.
10. Titball RW. Bacterial phospholipase C. Microbiol Rev 1993; 57:347-366.
11. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad H, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, Schumann RR. Bacterial endotoxin: chemical constitution, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.
12. Caroff M, Karibian D, Cavaillon JM, Haeffner-Cavaillon N. Structural and functional analysis of bacterial lipopolysaccharides. Microbes Infect 2002; 4:915-926.
13. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison CD. CD14, a receptor for complexes of lipopolysaccharides (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
14. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176:1665-1671.
15. Pugin J, Ulevitch RJ, Tobias PS. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 1993; 178:2193-2200.
16. Durieux JJ, Vita N, Popescu O, Guette F, Calzada-Wack J, Munker Schmidt RE, Lupker J, Ferrara P, Ziegler-Heitbrock HW, et al. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monoytes. Eur J Immunol 1994; 24:2006-2012.
17. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A 1993; 90:2744-2748.
18. Meyrick B, Hoover R, Jones MR, Berry LC Jr, Brigham, KL. In vitro effects of endotoxin on bovine and sheep lung microvascular endothelial cells and pulmonary artery endothelial cells. J Cell Physiol 1989; 138:165-174.
19. Goldblum SE, Ding X, Brann TW, Campbell-Washington J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J Cell Physiol 1993; 157:13-23.
20. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164:777-793.
21. Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 1988; 263:13479-13481.
22. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. Structure and function of lipopolysaccharide binding protein. Science 1990; 249:1429-1431.
23. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann Rev Immunol 1995; 13:437-457.
24. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 18:10482-10488.
25. Tapping RI, Tobias PS. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem 1997; 37:23157-23164.
26. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998; 95:588-593.
27. Qureshi ST, Lariviere L, Leveque G. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189:615-625.
28. Poltorak A, He X, Smirnova I, Liu M.-Y, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS-signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
29. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162:3749-3752.
30. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, Polentarutti N, Muzio M, Arditi M. Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000; 275:11058-11063.
31. Hijiya N, Miyake K, Akashi S, Matsuura K, Higuchi Y, Yamamoto S. Possible involvement of Toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide. Pathobiology 2002; 70:18-25.
32. Zeuke S, Ulmer A, Kusumoto S, Katus H, Heine H. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 2002; 56:126-134.
33. Jiang Q, Akashi S, Miyake K, Petty HR. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappaB. J Immunol 2000; 165:3541-3544.
34. Shimazu R, Akashi S, Ogata H. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189:1777-1782.
35. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, Miyake K. Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000; 164:3471-3475.
36. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11:115-122.
37. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Gosh S, Janeway C.A. MyD88 is an adapter protein in the hToll/IL-1 receptor family signaling pathway. Mol Cell Biol 1998; 2:253-258.
38. Akira S, Take K, Kaisho T. Toll-like receptors: critical protein inking innate and acquired immunity. Nat Immunol 2001; 2:675-680.
39. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997; 278:1612-1615.
40. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAM-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999; 27:19403-19410
41. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-κB and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 2000; 20:E83-E88.
42. Fischer W, Mannsfeld T, Hagen G. On the basic structure of poly(glycerophosphate) lipoteichoic acids. Biochem Cell Biol 1990; 68:33-43.
43. Fischer W, Markwitz S, Labischinski H. Small-angle X-ray scattering analysis of pneumococcal lipoteichoic acid phase structure. Eur J Biochem 1997; 244:913-917.
44. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64:1906-1912
45. Hattor Y, Kasai K, Akimoto K, Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun 1997; 233:375-379.
46. Takeuchi O, Hoshino K, Kawai T, Saanjo H, Takada H, Ogawa T, Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
47. Schwander R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 1999; 274:17406-17409.
48. Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 1991; 59:4614-4620.
49. Schleifer KH, Kandler O. Peptidoglycan types in the bacterial cell wall and their taxonomic implications. Bact Rev 1975; 36:407-477.
50. Weidemann B, Brade H, Rietschel ET, Dziarski R, Bazil V, Kusumoto S, Flad H, Ulmer AJ. Soluble peptido-glycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 1994; 62:4709-4715.
51. Gupta D, Kirkland TN, Viriyakosol S, Dziarski R. CD14 is a cell activation receptor for bacterial peptidoglycan. J Biol Chem 1996; 271:23310-23316.
52. Wang JE, Jorgensen PF, Almloef M, Thiemermann C, Foster SJ, Aasen AO, Solberg R. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 2000; 68:3965-3970.
53. Liu Y, Wang Y, Yamakuchi M, Isowaki S, Nagata E, Kanmura Y, Kitajima I, Maruyama I. Upregulation of Toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-κB activation. Infect Immun 2001; 69:2788-2796.
54. Van Langevelde P, Ravensbergen E, Grashoff P, Beekhuizen H, Groeneveld PHP, Dissel JT. Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes. Antimicrob Agents Chemother 1999; 43:2984-2989.
55. Füssle R, Bhakdi S, Sziegoleit A, Tranum-Jensen J, Kranz T, Wellensiek JH. On the mechanism of membrane damage by S. aureus alpha-toxin. J Cell Biol 1981; 91:83-94.
56. Bhakdi S, Mackman N, Nicaud JM, Holland IB. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun 1986; 52:63-69.
57. Bhakdi S, Tranum-Jensen J, Sziegoleit A. Mechanism of membrane damage by streptolysin-O. Infect Immun 1985; 47:52-60.
58. Walev I, Martin E, Jonas D, Mohamadzadeh M, Müller-Klieser W, Kunz L, Bhakdi S. Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions. Infect Immun 1993; 61:4972-4979.
59. Song L, Hobaugh MR, Shustak C, Cheley S, Baley H, Gouaux JE. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 1996; 274:1859-1866.
60. Valeva A, Weisser A, Walker B, Kehoe M, Bayley H, Bhakdi S, Palmer M. Molecular architecture of a toxin pore: a 15-residue sequence fines the transmembrane channel of staphylococcal alpha-toxin. EMBO J 1996; 15:1857-1864.
61. Valeva A, Walev I, Pinkernell M, Walker B, Bayley H, Palmer M, Bhakdi S. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A 1997; 94:11607-11611.
62. Welch RA. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol 1991; 5:521-529.
63. Bhakdi S, Greulich S, Muhly M, Eberspächer F, Becker H, Thiele A, Hugo F. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med 1989; 169:737-754.
64. Grimminger F, Sibelius U, Bhakdi S, Suttorp N, Seeger W. Escherichia coli hemolysin is a potent inductor of phophoinositide hydrolysis and related metabolic responses in human neutrophils. J Clin Invest 1991; 88:1531-1539.
65. Bhakdi S, Martin E, Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect Immun 1991; 107:147-223.
66. Welch RA, Dellinger EP, Minshew B, Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature 1981; 294:665-667.
67. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 1997; 30:685-692.
68. Gilbert RJ, Jimenez JL, Chen S, Tickle IJ, Rossjohn J, Parker M, Andrew PW, Saibil HR. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 1999; 28:647-655.
69. Alouf JE. Streptococcal toxins (streptolysin-O, streptolysin-S, erythrogenic toxin). Pharmacol Ther 1980; 11:661-717.
70. Buckingham L, Duncan JL. Approximate dimensions of membrane lesions produced by streptolysin-S and streptolysin-O. Biochim Biophys Acta 1983; 729:115-122.
71. Dramsi S, Cossart P. Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite. J Cell Biol 2002; 156:943-946.
72. Sibelius U, Chakraborty T, Krögel B, Wolf J, Rose F, Schmidt R, Wehland J, Seeger W, Grimminger F. The listerial exotoxins listeriolysin and phosphatidyl-inositol-specific phospholipase C synergize to elicit endothelial cell phosphoinositide metabolism. J Immunol 1996; 157:4055-4060.
73. Sibelius U, Rose F, Chakraborty T, Darji A, Wehland J, Weiss S, Seeger W, Grimminger F. Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells. Infect Immun 1996; 64:674-676.
74. Rose F, Zeller SA, Chakraborty T, Domann E, Machleidt T, Kronke M, Seeger W, Grimminger F, Sibelius U. Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect Immun 2001; 69:897-905.
75. Vazquez-Boland JA, Kuhn M, Berche P, Chakraborty T, Dominguez-Bernal G, Goebel W, Gonzalez-Zorn B, Wehland J, Kreft J. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 2001; 14:584-640.
76. Xiong G, Struckmeier M, Lutz F. Pore-foming Pseudomonas aeruginosa cytotoxin. Toxicology 1994; 87:69-83.
77. Sliwinski-Korell A, Engelhardt H, Kampka M, Lutz F. Oligomerization and structural changes of the pore-forming Pseudomonas aeruginosa cytotoxin. Eur J Biochem 1999; 265:221-230.
78. Seeger W, Birkemeyer RG, Ermert L, Suttorp N, Bhakdi S, Duncker HR. Staphylococcal α-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest 1990; 63:341-349.
79. Grimminger F, Rose F, Sibelius U, Meinhardt M, Pötzsch B, Spriestersbach R, Bhakdi S, Suttorp N, Seeger W. Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal α-toxin. J Immunol 1997; 159:1909-1916.
80. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, Bhakdi S. Small transmembrane pores created by staphylococcal alpha-toxin in T-lymphocytes evoke internucleosomal DNA-degradation. Infect Immun 1994; 62:1304-1312.
81. Walev I, Reske K, Palmer M, Valeva A, Bhakdi S. Potassium-inhibited processing of IL-1β in human monocytes. EMBO J 1995; 14:1607-1614.
82. Walev I, Vollmer P, Palmer S, Bhakdi S, Rose-John S. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci U S A 1996; 93:7882-7887.
83. Walev I, Palmer M, Martin E, Jonas D, Weller U, Hohn-Bentz H, Husmann M, Bhakdi S. Recovery of human fibroblasts from attack by the pore-forming alpha-toxin of Staphylococcus aureus. Microbial Pathogen 1994; 17:187-201.
84. Walev I, Bhakdi SC, Hofmann F, Djonder N, Valeva A, Aktories K, Bhakdi S. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A 2001; 98:3185-3190.
85. Valeva A, Walev I, Gerber A, Klein J, Palmer M, Bhakdi S. Staphylococcal alpha-toxin: repair of a calcium-impermeable pore in the target cell membrane. Mol Microbiol 2000; 36:467-476.
86. Walmrath D, Ghofrani HA, Rosseau S, Schütte H, Cramer A, Kaddus W, Grimminger F, Bhakdi S, Seeger W. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo-and exotoxin. J Exp Med 1994; 180:1437-1443.
87. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
88. Carter TD, Pearson JD. Regulation of prostacyclin synthesis in endothelial cells. News Physiol Sci 1992; 7:64-69.
89. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol 1992; 445:355-367.
90. Michiels C, Arnould T, Knott I, Dieu M, Remacle J. Stimulation of prostaglandin synthesis by human endothelial cells posed to hypoxia. Am J Physiol 1993; 264:C866-874.
91. Pohl U, Buss, R. Hypoxia stimulates release of endothelium-derive relaxant factor. Am J Physiol 1989; 256:H1595-1600.
92. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Gunther K, Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990; 247:1341-1344.
93. Hecker M, Mulsch A, Massenge E, Busse R. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol 1993; 265:H828-833.
94. Vanhoutte P, Mombouli JV. Vascular endothelium: vasoactive mediators. Prog Cardiovasc Dis 1996; 39:229-238.
95. Boulanger CM, Vanhoutte PM. G proteins and endothelium-dependent relaxations. J Vasc Res 1997; 34:175-185.
96. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
97. Whatley RE, Zimmerman GA, McIntyre LV, Prescott SM. Endothelium from diverse sources synthesizes platelet-activating factor. Arteriosclerosis 1988; 321-331.
98. 4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986; 261:16466-16472.
99. Forstermann U, Pollok JS, Schmidt HH, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A 1991 88:1788-1792.
100. Gross SS, Jaffe EA, Levi R, Kilbourn RG. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 1991; 178:823-829.
101. Szabo C, Thiemermann C. Mechanism of the induction of nitric oxide synthase. Adv Pharmacol 1995; 34:113-153.
102. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92:181-187.
103. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 1978; 9:145-158.
104. Ignarro LJ. Signal tranduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41:485-490.
105. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263:663-665.
106. Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci U S A 1992; 89:3917-3921.
107. Halushka PV, Mais DE, Mayeux PR, Morinelli TA. Thromboxane, prostaglandin and leukotriene receptors. Annu Rev Pharmacol Toxicol 1989; 10:213-239.
108. Quilley J, Fulton D, McGiff JC. Hyperpolarizing factors. Biochem Pharmacol 1997; 54:1059-1070.
109. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrom P450 2C is an EDHF in coronary arteries. Nature 1999; 401:493-497.
110. Inoue A, Yanagisawa M, Kimura S, Kayasu Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 1989; 86:2863-2867.
111. Douglas SA, Ohlstein EH. Signal transduction mechanisms mediating the vascular act of endothelin. J Vasc Res 1997; 34:152-164.
112. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 2001; 41:851-876.
113. Golden CL, Kohler JP, Nick HS, Visner GA. Effects of vasoactive and inflammatory mediators on endothelin-1 expression in pulmonary endothelial cells. Am J Respir Cell Mol Biol 1995; 12:503-512.
114. Whatley RE, Zimmerman GA, McIntyre TM, Prescott SM. Endothelium from diverse vascular sources synthesizes platelet activating factor. Arteriosclerosis 1988; 8:321-331.
115. Chilton FH, Ellis JM, Olson SC, Wykle RL. 1-O-alcyl-2-arachidonyl-sn-glycero-3-phosphocholien. A. common source of platelet activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem 1984; 259:12014-12019.
116. Davidson D, Singh M, Wallace GF. Role of leukotriene C4 in pulmonary hypertension: platelet activating factor vs. hypoxia. J Appl Physiol 1990; 68:1628-1633.
117. Hu W, Kinnaird AAA, Man RYK. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Br J Pharmacol 1991; 103:1097-1102.
118. 4. Eur J Biochem 1988; 173:93-100.
119. 4 in blood-free perfused rabbit lungs. J Immunol 1988; 141:2431-2436.
120. Grimminger F, Mayer K, Kiss L, Wahn H, Walmrath D, Seeger W. Synthesis of 4- and 5-series leukotrienes in the lung microvasculature challenged with E. coli hemolysin: critical dependence on exogenous free fatty acid supply. Am J Respir Cell Mol Biol 1997; 16:317-324.
121. Grimminger F, Wahn H, Mayer K, Kiss L, Walmrath D, Seeger W. Impact of arachidonic versus eicosapentaenoic acid on exotoxin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med 1997; 155:513-519.
122. Grimminger F, Thomas M, Obernitz R, Walmrath D, Bhakdi S, Seeger W. Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature. J Exp Med 1990; 172:1115-1125.
123. Grimminger F, Walmrath D, Birkemeyer R.G, Bhakdi S, Seeger W. Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs. Infect Immun 1990; 58:2659-2663.
124. Grimminger F, Kreusler B, Schneider U, Becker G, Seeger W. Influence of microvascular adherence on neutrophil leukotriene generation - evidence for cooperative eicosanoid synthesis. J Immunol 1993; 144:1866-1872.
125. Figard PH, Hejlik DP, Kaduce TL, Stoll LL, Spector AA. Free fatty acid release from endothelial cells. J Lipid Res 1986; 27:771-780.
126. Groeneveld AB, Hartemink KJ, de Groot MC, Visser J, Thijs LG. Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock 1999; 11:160-166.
127. Gross SS, Kilbourn RG, Griffith OW. NO in septic shock: good, bad of ugly? Learning from iNOS knock-outs. Trends Microbiol 1996; 4:47-49.
128. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558.
129. Wang P, Ba ZF, Chaudry IH. Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am J Physiol 1995; 269:R988-R994.
130. Zhou M, Wang P, Chaudry IH. Endothelial nitric oxides synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta 1997; 1335:182-190.
131. Kristof AS, Noorhosseini H, Hussain SN. Attenuation of endothelium-dependent hyperpolarizing factor by bacterial lipopolysaccharides. Eur J Pharmacol 1997; 328:69-73.
132. Kessler P, Popp R, Busse R, Schini-Kerth VB. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 1999; 99:1878-1884.
133. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267:L223-L241.
134. 2+, and junctions in endothelial hyperpermeability. Circ Res 2000; 87:268-271.
135. Wysolmerski RB, Lagunoff D. Involvement of myosin light chain kinase in endothelial cell retraction. Proc Natl Acad Sci U S A 1990; 87:16-20.
136. Verin AD, Patterson CE, Day MA, Garcia JGN. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 1995; 269:L99-L108.
137. Aepfelbacher M, Essler M. Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: A role of rho/rho kinase. Cell Microbiol 2001; 3:649-658.
138. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8:504-512.
139. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 379-387.
140. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992; 258:964-996.
141. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992; 13:93-100.
142. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75:1037-1050.
143. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178:449-460.
144. Vaporciyan AA, DeLisser HM, Yan H.-C, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993; 262:1580-1582.
145. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Biol Chem 1993; 120:1371-1380.
146. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-376.
147. Esmon CT. Protein C pathway in sepsis. Ann Med 2002; 34:598-605.
148. Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem 1992; 267:20435-20443.
149. Iversen N, Sandset PM, Abildgaard U, Torjesen PA. Binding of tissue factor pathway inhibitor to cultured endothelial cells - influence of glycosaminoglycans. Thromb Res 1996; 84:267-278.
150. Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991; 88:1690-1699.
151. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586-592.
152. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340:155-1564.
153. Drake TA, Cheng J, Chang A, Taylor FB Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons wit lethal Escherichia coli sepsis. Am J Pathol 1993; 2:1458-1470.
154. Crossman DC, Carr DP, Tuddenham EG, Pearson JD, McVey JH. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol esters. Biol Chem 1990; 265:9782-9787.
155. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrande factor in patients with severe infection. Am J Respir Crit Care Med 1998; 157:776-784.
156. Cummings JC, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowller, AA III. Soluble E-selectin levels in sepsis and critic illness. Am J Respir Crit Care Med 1997; 156:431-437.
157. Boldt J, Wollbruck T, Sonneborn S, Welters A, Hempelmann G. Thrombomodulin in intensive care patients. Intensive Care Med 1995; 21:645-650.
158. Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, Lu JM, Montgomery AB, Marks JD, Matthay MA. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary psis syndrome. J Clin Invest 1990; 86:474-480.
159. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI, Baudouin SV. Circulating endothelial cell in patients with septic shock. Am J Respir Crit Care Med 2001; 163:195-200.
160. 2 production in endothelial cells: role of calcium. Am J Physiol 1985; 248:127-134.
161. Suttorp N, Floer B, Schnittler H, Seeger W, Bhakdi S. Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun 1990; 58:3796-3801.
162. Suttorp N, Buerke M, Tannert-Otto S. Stimulation of PAF-synthesis in pulmonary artery endothelial cells by Staphylococcus aureus alpha-toxin. Thromb Res 1992; 67:243-252.
163. Suttorp N, Fuhmann M, Tannert-Otto S, Griminger F, Bhakdi S. Pore-forming bacterial toxins potently induce release nitric oxide in porcine endothelial cells. J Exp Med 1993; 178:337-341.
164. Suttorp N, Seeger W, Zucker-Reimann J, Roka L, Bhakdi S. Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin. Infect Immun 1987; 55:104-110.
165. 2+ in polymorphonuclear leukocytes. Infect Immun 1988; 56:2228-2234.
166. Suttorp N, Seeger W, Uhl J, Lutz F, Roka L. Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: membrane attack and calcium influx. J Cell Physiol 1985; 123:64-72.
167. Radomski MW, Palmer RM, Moncada S. Glucocorticoide inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990; 87:10043-10047.
168. Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol 1997; 121:125-133.
169. Walter R, Schaffner A, Schoedon G. Differential regulation of constitutive and inducible nitric oxide production by inflammatory stimuli in murine endothelial cells. Biochem Biophys Res Commun 1994; 202:450-455.
170. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of three isoforms. Naunyn Schmiedebergs Arch Pharmacol 1995; 352:351-364.
171. Forstermann U, Boissel JP, Kleinert H. Expressional control of the constitutive isoform of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12:773-790.
172. Morikawa A, Koide N, Karo Y, Sugiyama T, Chakravortty D, Yoshida T, Yokochi T. Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 2000; 68:6209-6214.
173. Schaffner A, Blau N, Schneemann M, Steurer J, Edgell CJ, Schoedon G. Tetrahydrobiopterin as another EDRF in man. Biochem Biophys Res Commun 1994; 205:516-523.
174. Javeshghani J, Magder S. Regional changes in constitutive nitric oxide synthase and the hemodynamic consequences of its inhibition in lipopolysaccharide-treated rats. Shock 2001; 16:232-238.
175. Akarasereenont P, Mitchell JA, Appleton I, Thiemermann C, Vane JR. Involvement of tyrosine kinase in induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells. Br J Pharmacol 1994; 113:1522-1528.
176. Akarasereenont P, Bakhle YS, Thiemermann C, Vane JR. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. Br J Pharmacol 1995; 115:401-408.
177. Imaizumi T, Aratani S, Nakajima T, Carlson M, Matsumiya T, Tanji K, Ookawa K, Yoshida H, Tsuchida S, McIntyre TM, Prescott SM, Zimmerman GA, Satoh K. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of Cox-2. Biochem Biophys Res Commun 2002; 292:274-279.
178. Chen JX, Berry LC Jr, Christman BW, Tanner M, Myers PR, Meyrick BO. NO regulates LPS-stimulated cyclooxygenase gene expression and activity in pulmonary artery cells. Am J Physiol 2001; 280:L450-L457.
179. Dil N, Qureshi MA. Involvement of lipopolysaccharide related receptors and nuclear factor κB in differential expression of inducible nitric oxide synthase in chicken macrophages from different genetic backgrounds. Vet Immunol Immunopathol 2002; 88:149-161.
180. Schilling D, Thomas K, Nixdorff K, Vogel SN, Fenton MJ. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J Immunol 2002; 169:5874-5880.
181. Nakamura T, Kasai K, Sekiguchi Y, Banba N, Takahashi K, Emoto T, Hattori Y, Shimoda S. Elevation of plasma endothelin concentrations during endotoxin shock in dogs. Eur J Pharmacol 1991; 205:277-282.
182. Suttorp N, Hessz T, Seeger W, Wilke A, Koob R, Lutz F, Drenckhahn D. Bacterial exotoxins and endothelial permeability for water and albumin in vitro. Am J Physiol 1988; 255:C368-C376.
183. Goldblum SE, Brann TW, Ding X, Pugin J, Tobias PS. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J Clin Invest 1994; 93:692-702.
184. Bannerman DD, Goldblum SE. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation. Am J Physiol 1997; 273:L217-L226.
185. Essler M, Staddon J, Weber PC, Aepfelbacher M. Cyclo-AMP blocks bacterial lipopolysaccharide induced myosin light chain phophorylation in endothelial cells through inhibition of Rho/Rho-kinase-signaling. J Immunol 2000; 164:6543-6549.
186. Bannerman DD, Sathyamoorthy M, Goldblum SE. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem 1998; 273:35371-35380.
187. Messmer UK, Briner VA, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 1999; 55:2332-2337.
188. Krüll M, Dold C, Hippenstiel S, Rosseau S, Lohmeyer J, Suttorp N. Escherichia coli hemolysin and Staphylococcus aureus α-toxin potently induce neutrophil adhesion to cultured human endothelial cells. J Immunol 1996; 157:4133-4140.
189. Krüll M, Nöst R, Hippenstiel S, Domann E, Chakraborty T, Suttorp N. Listeria monocytogenes potently induces up-regulation of endothelial adhesion molecules and neutrophil adhesion to cultured human endothelial cells. J Immunol 1997; 159:1970-1976.
190. Buerke M, Sibelius U, Grandel U, Buerke U, Grimminger F, Seeger W, Meyer J, Darius H. Staphylococcus aureus alpha toxin mediates polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Shock 2002; 17:30-35.
191. Prüfer D, Makowski J, Schnell M, Buerke U, Dahm M, Oelert H, Sibelius U, Grandel U, Grimminger F, Seeger W, Meyer J, Darius H, Buerke M. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 2002; 106:2104-2110.
192. Wilson SL, Drevets DA. Listeria monocytogenes infection and activation of human brain microvascular endothelial cells. J Infect Dis 1998; 178:1658-1666.
193. Drevets DA. Listeria monocytogenes virulence factors that stimulate endothelial cells. Infect Immun 1998; 66:232-238.
194. Kayal S, Lilienbaum A, Poyart C, Memet S, Israel A, Berche P. Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-κB and upregulation of adhesion molecules and chemokines. Mol Microbiol 1999; 31:1709-1722.
195. Grandel U, Reutemann M, Kiss L, Buerke M, Fink L, Bournelis E, Heep M, Seeger W, Grimminger F, Sibelius U. Staphylococcal α-toxin provokes neutrophil-dependent cardiac dysfunction: role of ICAM-1 and cysleukotrienes. Am J Physiol 2002; 282:H1157-H1165.
196. Kawamura N, Imanishi N, Koike H, Nakahara H, Phillips L, Morooka S. Lipoteichoic acid-induced neutrophil adhesion via E-selectin to human umbilical vein endothelial cells. Biochem Biophys Res Commun 1995; 217:1208-1215.
197. Blease K, Chen Y, Hellewell PG, Burke-Gaffney A. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cell. J Immunol 1999; 163:6139-6147.
198. Yipp BG, Andonegui G, Howlett CJ, Robbins SM, Hartung T, Ho M, Kubes P. Profound differences in leukocyte-endothelial cell responses to lipopolysaccharide versus lipoteichoic acid. J Immunol 2002; 168:4650-4658.
199. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78:747-754.
200. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79:124-130.
201. Matsumoto H, Ueshima S, Fukao H, Mitsui Y, Matsuo O. Effects of lipopolysaccharide on the expression of fibrinolytic factors in an established cell line from human endothelial cells. Life Sci 1996; 59:85-96.
202. Bodin P, Burnstock G. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 1998; 47:351-354.
203. Beck GC, Oberacker R, Kapper S, von Zabern D, Schulte J, van Ackern K, van der Woude FJ, Yard BA. Modulation of chemokine production in lung microvascular endothelial cells by dopamine is mediated via an oxidative mechanism. Am J Respir Cell Mol Biol 2001; 25:636-643.
204. Soderquist B, Kallman J, Holmberg H, Vikerfors T, Kihlstrom E. Secretion of IL-6, IL-8 and G-CSF by human endothelial cells in vitro in response to Staphylococcus aureus and staphylococcal exotoxins. APMIS 1998; 106:1157-1164.
205. Seeger W, Bauer M, Bhakdi S. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest 1984; 74:849-858.
206. Walmrath D, Scharmann M, Konig R, Pilch J, Grimminger F, Seeger W. Staphylococcal alpha-toxin induced ventilation-perfusion mismatch in isolated blood-free perfused rabbit lungs. J Appl Physiol 1993; 74:1972-1980
207. Seeger W, Walter H, Suttorp N, Muhly M, Bhakdi S. Thromboxane-mediated hypertension and vascular leakage evoked low doses of Escherichia coli hemolysin in rabbit lungs. J Clin Invest 1989; 84:220-227.
208. Seeger W, Obernitz R, Thomas W, Walmrath D, Suttorp N, Holland IB, Grimminger F, Eberspacher B, Hugo F, Bhakdi S. Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated A rabbit lungs. Am Rev Respir Dis 1991; 143:797-805.
209. Ermert L, Rosseau S, Schutte H, Birkemeyer RG, Grimminger F, Bhakdi S, Duncker HR, Seeger W. Induction of severe vascular leakage by low doses of Escherichia coli emolysin in perfused rabbit lungs. Lab Invest 1992; 66:362-369.
210. Schütte H, Mayer K, Gessler T, Rühl M, Schlaudrauff J, Burger H, Seeger W, Grimminger F. Nitric oxide biosynthesis in an exotoxin-induced septic lung model. Am J Respir Crit Care Med 1998; 157:498-504.
211. Seeger W, Walmrath D, Neuhof H, Lutz F. Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs. Infect Immun 1986; 2:846-852.
212. Grimminger F, Walmrath D, Walter H, Lutz F, Seeger W. Induction of vascular injury by Pseudomonas aeruginosa cytotoxin in rabbit lungs is associated with the generation of different leukotrienes and hydroxyeicosatetraenoic acids. J Infect Dis 1991; 163:362-370.
213. Walmrath D, Griebner M, Kolb B, Grimminger F, Galanos C, Schade U, Seeger W. Endotoxin primes perfused rabbit lungs for enhanced vasoconstrictor response to staphylococcal alpha-toxin. Am Rey Rev Respir Dis 1993; 148:179-1186.
214. Walmrath D, Pilch J, Scharmann M, Grimminger F, Seeger W. Severe VA/Q mismatch in perfused lungs evoked by sequential challenge with endotoxin and E. coli hemolysin. J Appl Physiol 1994; 76:1020-1030.
215. Walmrath D, Ghofrani HA, Grimminger F, Seeger W. Synergism alveolar endotoxin priming and exotoxin challenge lung injury. Am J Respir Crit Care Med 1996; 154:460-468.
216. Schütte H, Rosseau S, Czymek R, Ermert L, Walmrath D, Kramer HJ, Seeger W, Grimminger F. Synergism between endotoxin priming and exotoxinchallenge in provoking severe vascular leakage in rabbit lungs. Am J Respir Crit Care Med 1997; 156:819-824.
217. Steudel W, Kramer HJ, Degner D, Rousseau S, Schutte H, Walmrath D, Seeger W. Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs. J Appl Physiol 1997; 83:18-24.
218. Ermert L, Ermert M, Goppelt-Struebe M, Walmrath D, Grimminger F, Steudel W, Ghofrani HA, Homberger C, Duncker HR, Seeger W. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol 1998; 18:479-488.
219. 2 synthase in normal and LPS-primed lungs. Am J Physiol 2000; 278:L744-L753.
220. Ermert L, Ermert M, Merkle M, Goppelt-Struebe M, Duncker HR, Grimminger F, Seeger W. Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge. Differential regulation in the various types of cells in the lung. Am J Pathol 2000; 156:1275-1287.
221. Ermert M, Merkle M, Mootz R, Grimminger F, Seeger W, Ermert L. Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs. Am J Physiol 2000; 278:L1195-L1293.
222. Ermert M, Ruppert C, Günther A, Duncker H.-R, Seeger W, Ermert L. Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 2002; 82:425-441.
223. Hinder F, Stubbe HD, van Aken H, Waurick R, Booke M, Meyer J. Role of nitric oxide in sepsis-associated pulmonary edema. Am J Respir Crit Care Med 1999; 159:252-257.
224. Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 2001; 15:364-376.
225. Kumar A, Krieger A, Symeides S, Kumar A, Parrillo JE. Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 2001; 15:485-511.
226. Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ. Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 1990; 107:397-410.
227. Avontuur JA, Bruining HA, Ince C. Inhibition of nitric oxide synthesis causes ischemia in endotoxemic rats. Circ Res 1995; 76:418-425.
228. Groeneveld ABJ, van Lambalgen AA, van den Bos GC, Nauta JJP, Thijs LG. Maldistribution of heterogenous coronary blood flow during canine endotoxin shock. Cardiovasc Res 1991; 25:80-88.
229. Fox GA, Bersten A, Lam C, Neal A, Rutledge FS, Inman K, Sibbald WJ. Hematocrit modifies the circulatory control of systemic and myocardial oxygen utilization in septic sheep. Crit Care Med 1994; 22:470-479.
230. Bloos FM, Morisaki HM, Neal AM, Martin CM, Ellis CG, Sibbald WJ. Sepsis depresses the metabolic oxygen reserve of the coronary circulation in mature sheep. Am J Respir Crit Care Med 1996; 153:1577-1584.
231. Granton JT, Goddard CM, Allard MF, Van Eeden S, Walley KR. Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits. Am J Respir Crit Care Med 1997; 155:1977-1983.
232. Comstock KL, Krown KA, Page MT, Martin D, Ho P, Redraza M, Castro EN, Nakajima N, Glembotskis CC, Quintana PJE, Sabbadini RA. LPS-induced TNF-α release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 1998; 30:2761-2775.
233. Oral H, Dorn GW II, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1997; 272:4836-4842.
234. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389.
235. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105:575-580.
236. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995; 96:1042-1052.
237. Grandel U, Fink L, Blum A, Heep M, Buerke M, Kraemer HJ, Mayer K, Bohle RM, Seeger W, Grimminger F, Sibelius U. Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 2000; 102:2758-2764.
238. Baumgarten G, Knuefermann P, Nozaki N, Sivasubramanian N, Mann DL, Vallejo JG. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of Toll-like receptor-4. J Infect Dis 2001; 183:1617-1624.
239. Nemoto S, Vallejo JG, Knuefermann P, Misra A, Defreitas G, Carabello BA, Mann DL. Escherichia coli LPS-induced LV dysfunction: roll of Toll-like receptor-4 in the adult heart. Am J Physiol 2002; 282:H2316-H2323.
240. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999; 104:271-280.
241. Sibelius U, Grandel U, Buerke M, Mueller D, Kiss L, Kraemer HJ, Braun-Dullaeus R, Haberbosch W, Seeger W, Grimminger F. Staphylococcal α-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts. Role of thromboxane generation. Circulation 2000; 101:78-85.
242. Grandel U, Sibelius U, Schrickel J, Schmidt D, Buerke M, Fink L, Bournelis E, Heep M, Mayer K, Bohle RM, Seeger W, Grimminger F. Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin. Crit Care Med 2001; 29:1-7.
243. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units - causes, outcome, and prognostic factors of hospital mortality, a prospective, multicenter study. French study group on acute renal failure. Crit Care Med 1996; 94:192-198.
244. Lugon JR, Boim MA, Ramos OL, Ajzen H, Schor N. Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 1989; 36:570-575.
245. Kreft B, Pagel H. Virulence factors of Escherichia coli contribute to acute renal failure. Exp Nephrol 2000; 8:244-251.
246. Conger J. Hemodynamic factors in acute renal failure. Adv Ren Replace Ther 1997; 4:S25-S37.
247. Cohen JJ, Black AJ, Wertheim SJ. Direct effects of endotoxin on the function of the isolated perfused rat kidney. Kidney Int 1990; 37:1219-1226.
248. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168:5817-5823.
249. Schor N. Acute renal failure and the sepsis syndrome. Kidney Int 2002; 61:764-776.
250. Linas SL, Whittenburg D, Repine JE. Role of neutrophil derived oxidants and elastase in lipopolysaccharide-mediated renal injury. Kidney Int 1991; 39:618-623.
251. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996; 20:411-417.
252. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, Leroy Thuillez C, Lebreton JP. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 1997; 273:G314-G321.
253. Komatsu S, Panes J, Grisham MB, Russell JM, Mori N, Granger DN. Effects of intestinal stasis on intercellular adhesion molecule expression in the rat: role of enteric bacteria. Gastroenterology 1997; 112:1971-1978.
254. Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA, Granger DN. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res 1996; 79:560-569.
255. Bauer P, Russell JM, Granger DN. Role of endotoxin in intestinal reperfusion-induced expression of E-selectin. Am J Physiol 1999; 276:G479-G484.
256. Mayer K, Temmesfeld-Wollbrück B, Friedland A, Olschewski H, Reich M, Seeger W, Grimminger F. Severe microcirculatory abnormalities elicited by E. coli hemolysin in the rabbit ileum mucosa. Am J Respir Crit Care Med 1999; 160:1171-1178.
257. Hanasawa K. Extracorporeal treatment for septic patients: new adsorption technologies and their clinical application. Ther Apher 2002; 6:290-295.
258. Ullrich H, Jakob W, Fröhlich D, Rothe G, Praser C, Drobnik W, Taeger K, Meier-Hellmann A, Reinhart K, Zimmermann M, Schmitz G. A new endotoxin adsorber: first clinical application. Ther Apher 2001; 5:326-334.
259. Bhakdi S, Mannhardt H, Ronneberger R, Hungerer KD. Human hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin on human monocytes. Infect Immun 1989; 57:3214-3220.
260. Bhakdi S, Jursch R, Broker M, Ronneberger H, Hungerer KD. Functionally inactive S. aureus alpha-toxin containing a single amino acid substitution: potential usefulness as a vaccine. Behring Inst Mitt 1994:80-84.
261. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington J, Wherry J. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 1995; 273:934-941.